» Articles » PMID: 23342037

Expansion on Stromal Cells Preserves the Undifferentiated State of Human Hematopoietic Stem Cells Despite Compromised Reconstitution Ability

Overview
Journal PLoS One
Date 2013 Jan 24
PMID 23342037
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Lack of HLA-matched hematopoietic stem cells (HSC) limits the number of patients with life-threatening blood disorders that can be treated by HSC transplantation. So far, insufficient understanding of the regulatory mechanisms governing human HSC has precluded the development of effective protocols for culturing HSC for therapeutic use and molecular studies. We defined a culture system using OP9M2 mesenchymal stem cell (MSC) stroma that protects human hematopoietic stem/progenitor cells (HSPC) from differentiation and apoptosis. In addition, it facilitates a dramatic expansion of multipotent progenitors that retain the immunophenotype (CD34+CD38-CD90+) characteristic of human HSPC and proliferative potential over several weeks in culture. In contrast, transplantable HSC could be maintained, but not significantly expanded, during 2-week culture. Temporal analysis of the transcriptome of the ex vivo expanded CD34+CD38-CD90+ cells documented remarkable stability of most transcriptional regulators known to govern the undifferentiated HSC state. Nevertheless, it revealed dynamic fluctuations in transcriptional programs that associate with HSC behavior and may compromise HSC function, such as dysregulation of PBX1 regulated genetic networks. This culture system serves now as a platform for modeling human multilineage hematopoietic stem/progenitor cell hierarchy and studying the complex regulation of HSC identity and function required for successful ex vivo expansion of transplantable HSC.

Citing Articles

MYCT1 controls environmental sensing in human haematopoietic stem cells.

Aguade-Gorgorio J, Jami-Alahmadi Y, Calvanese V, Kardouh M, Fares I, Johnson H Nature. 2024; 630(8016):412-420.

PMID: 38839950 PMC: 11168926. DOI: 10.1038/s41586-024-07478-x.


AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells.

Manesia J, Maganti H, Almoflehi S, Jahan S, Hasan T, Pasha R Cell Rep Methods. 2023; 3(12):100663.

PMID: 38070507 PMC: 10783628. DOI: 10.1016/j.crmeth.2023.100663.


Small Molecule Screening of Primary Human Acute Myeloid Leukemia Using Co-culture and Multiplexed FACS Analysis.

Baudet A, Hultmark S, Ek F, Magnusson M Bio Protoc. 2022; 12(6):e4353.

PMID: 35434186 PMC: 8983156. DOI: 10.21769/BioProtoc.4353.


Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells.

Hultmark S, Baudet A, Schmiderer L, Prabhala P, Palma-Tortosa S, Sanden C Haematologica. 2020; 106(10):2566-2577.

PMID: 32855276 PMC: 8485661. DOI: 10.3324/haematol.2020.249177.


Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.

Daniel M, Sachs D, Bernitz J, Fstkchyan Y, Rapp K, Satija N FEBS Lett. 2019; 593(23):3266-3287.

PMID: 31557312 PMC: 6901732. DOI: 10.1002/1873-3468.13621.


References
1.
Le Blanc K, Ringden O . Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007; 262(5):509-25. DOI: 10.1111/j.1365-2796.2007.01844.x. View

2.
Jude C, Gaudet J, Speck N, Ernst P . Leukemia and hematopoietic stem cells: balancing proliferation and quiescence. Cell Cycle. 2008; 7(5):586-91. PMC: 2892629. DOI: 10.4161/cc.7.5.5549. View

3.
Collins L, Dorshkind K . A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol. 1987; 138(4):1082-7. View

4.
Pevny L, Simon M, Robertson E, Klein W, Tsai S, DAgati V . Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991; 349(6306):257-60. DOI: 10.1038/349257a0. View

5.
Miller C, Eaves C . Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci U S A. 1998; 94(25):13648-53. PMC: 28360. DOI: 10.1073/pnas.94.25.13648. View